[Overdue] The Lancet is the world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. Available onweb first. Free registration.DF Afatinib for patients with lung adenocarcinoma and epidermal growth factor mutations (LUX-Lung 2...
